Chemed Corporation (CHE)
Last Price$550.6(0.9%)
Market Cap$8,290.2M
WACC
7.6%
Cost of Equity
7.7%
Cost of Debt
0.2%
Debt to Equity
1.8%
Beta
1.0
Stock quality
7/10
Good
CHE WACC
Crunching data... Almost there!
Best stock ideas on the market right now
With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.
CHE Cost of Equity
Crunching data... Almost there!
CHE vs Peer Set: Discount Rate Comparison
WACC
Cost of Equity
General
Discount rate
financials
Company name
Revenue growth
EPS growth
Net Income margin
Chemed CorporationCHE
7.6%
6.1%
8.3%
12.0%
Median Peer Set
7.3%
7.5%
0.0%
5.4%
HCA Healthcare, Inc.HCA
11.0%
7.9%
(1.0%)
8.1%
Option Care Health, Inc.OPCH
8.8%
9.1%
79.5%
6.2%
Encompass Health CorporationEHC
8.1%
11.9%
28.8%
8.5%
Universal Health Services, Inc.UHS
7.6%
6.6%
12.1%
5.0%
Amedisys, Inc.AMED
7.3%
0.6%
N/A
(0.4%)
Acadia Healthcare Company, Inc.ACHC
7.3%
12.2%
N/A
(0.7%)
The Ensign Group, Inc.ENSG
7.0%
14.2%
39.9%
7.0%
Tenet Healthcare CorporationTHC
6.4%
7.2%
(37.1%)
3.0%
Fresenius Medical Care AG & Co. KGaAFMS
4.8%
2.9%
(24.2%)
2.6%
DaVita Inc.DVA
4.4%
4.6%
(7.7%)
5.7%
Explore more intrinsic value tools hub for CHE
Peter Lynch Fair Value
Margin of safety
Reverse DCF
Relative Value
DCF value calculator
Ben Graham Fair Value
Intrinsic Value
Peter Lynch charts
Earnings growth model
Earnings Power Value
FAQ
What is Chemed Corporation's discount rate as of Feb 20, 2025?
As of Feb 20, 2025, Chemed Corporation's discount rate is 7.59%. This rate is determined based on the weighted average cost of capital (WACC) and the cost of equity, factoring in Chemed Corporation's capital structure and risk profile.
What is Chemed Corporation's weighted average cost of capital (WACC)?
Chemed Corporation's WACC as of Feb 20, 2025, is 7.59%. This value is calculated by blending the cost of debt and cost of equity, reflecting the company’s overall cost of financing its operations.
What is Chemed Corporation's cost of equity?
Chemed Corporation's cost of equity is 7.7%, as of Feb 20, 2025. This is the return that shareholders expect based on the stock's risk level and market conditions, used to calculate the discount rate for valuing future cash flows.